translation agency

AIDS Treatment News
Merck Protease Inhibitor: New International
John S. James
April 21, 1995
AIDS TREATMENT NEWS Issue #221, April 21, 1995

The last issue of AIDS TREATMENT NEWS gave contact numbers for information about volunteering for trials of MK-639, the experimental protease inhibitor developed by Merck and Co. Since we went to press, the numbers for Canada, Spain, and Switzerland have changed. All other numbers are the same.

In Canada, call Dr. Dr. Alain Prat, 514/428-2639. In Spain, call Dr. Jorge Gonzalez Esteban, 34-1-742-6012. In Switzerland, call Dr. Martin Fenner, 41-1-828-7111.

The other contacts are: in France, Dr. Marc Bratzlavsky, 33- 1-47-54-89-90; in Germany, Dr. Gunter Janhofer, 49-89-45-61- 1104; in the U.S., call the Merck Protease Inhibitor Information Line, 800/379-1332, between 8 a.m. and 7 p.m. Eastern time Monday through Friday.

www.aegis.org